Understand the source comparison
Best Wolverine Stack Dosage for Injury Support: Evidence-Based Comparison
| Peptide | Standard Dose | Frequency | Half-Life | Primary Mechanism | Injection Timing | Clinical Evidence ||—|—|—|—|—|—|| BPC-157 | 250–500mcg | Once daily | 4 hours | VEGF upregulation, angiogenesis, NO stabilization | Morning, near injury site if accessib
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- | Peptide | Standard Dose | Frequency | Half-Life | Primary Mechanism | Injection Timing | Clinical Evidence ||—|—|—|—|—|—|| BPC-157 | 250–500mcg | Once daily | 4 hours | VEGF upregulation, angiogenesis, NO stabilization | Morning, near injury site if accessible | University of Zagreb tendon studies: 58% faster healing vs controls || TB-500 | 2–2.5mg | Twice weekly (3-4 day intervals) | 7–10 days (therapeutic window 48–72 hours) | Actin sequestration, cell migration, anti-inflammatory cytokine suppression | Monday/Thursday schedule maintains overlap | 40–50% reduction in IL-6/TNF-alpha markers in animal models || GHK-Cu | 1–2mg | Three times weekly | 36–48 hours | Copper delivery to metalloproteinases, decorin upregulation, collagen remodeling | Mon/Wed/Fri or equivalent spacing | Plasma levels decline 60% from age 20 to 60; supplementation restores remodeling capacity || Full Stack | Combined protocol | Overlapping schedules | N/A | Synergistic coverage of vascularization, inflammatio